You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Folfirinox

Showing 26 - 50 of 321
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic Trial in Boston (FOLFIRNINOX, Losartan, 9-ING-41)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Adenocarcinoma Metastatic
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jun 7, 2022

Cancer Of Pancreas Trial (Analyze of GemCore status)

Not yet recruiting
  • Cancer Of Pancreas
  • Analyze of GemCore status
  • (no location specified)
Sep 19, 2023

ADjuvant chemotherAPy After Curative Intent resecTion of

Recruiting
  • Ampullary Adenocarcinoma
  • Brescia, BS, Italy
    Fondazione Poliambulanza
Oct 3, 2023

Metastatic Pancreatic Ductal Adenocarcinoma Trial in France, Spain (CAN04, FOLFIRINOX)

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Bordeaux, France
  • +7 more
May 16, 2022

Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022

Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)

Recruiting
  • Pancreas Cancer
  • Adenocarcinoma of the Pancreas
  • Omaha, Nebraska
    University of Nebraska Medical Center
Mar 31, 2022

Resectable Pancreatic Adenocarcinoma Trial in Seoul (neoadjuvant modified FOLFIRINOX)

Recruiting
  • Resectable Pancreatic Adenocarcinoma
  • neoadjuvant modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ.
Sep 23, 2021

Pancreatic Cancer Trial in Germany (Induction chemo with gemcitabine or FOLFIRINOX, Radiotherapy, 28 x 1.8 Gy, Chemotherapy,

Active, not recruiting
  • Pancreatic Cancer
  • Induction chemotherapy with gemcitabine or FOLFIRINOX
  • +3 more
  • Bayreuth, Germany
  • +22 more
Jun 15, 2022

Colon Cancer, Pancreas Cancer, Digestive Cancer Trial in Fairway, Kansas City, North Kansas City (CEND-1, Panitumumab,

Recruiting
  • Colon Cancer
  • +2 more
  • Fairway, Kansas
  • +2 more
Nov 16, 2021

Biliary Tract Cancer Trial in Riyadh (FOLFIRINOX)

Recruiting
  • Biliary Tract Cancer
  • FOLFIRINOX
  • Riyadh, Saudi Arabia
    king Faisal Specialist Hospital and Research Center
Aug 30, 2021

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic body radiotherapy (SBRT)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Sep 15, 2023

Pancreatic Adenocarcinoma, Pancreatic Cancer Resectable Trial in Cádiz (Folfirinox and Stereotactic Body Radiotherapy)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Cancer Resectable
  • Folfirinox and Stereotactic Body Radiotherapy
  • Cádiz, Spain
    Hospital Puerta del Mar
Aug 5, 2022

Pancreatic Cancer Trial in Boston (drug, radiation, procedure)

Active, not recruiting
Has Results
  • Pancreatic Cancer
  • FOLFIRINOX
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
May 5, 2021

Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • ctDNA Blood Test
  • +8 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University
Feb 8, 2023

Metastatic Pancreatic Cancer Trial in Long Branch, New Brunswick (Folfirinox alternating with Gemcitabine-nab-Paclitaxel)

Recruiting
  • Metastatic Pancreatic Cancer
  • Folfirinox alternating with Gemcitabine-nab-Paclitaxel
  • Long Branch, New Jersey
  • +1 more
Jun 8, 2021

Metastatic Pancreatic Cancer Trial in Montreal (Salmonella-IL2, FOLFIRINOX Alone (Historical Controls), Gemcitabine/Abraxane

Recruiting
  • Metastatic Pancreatic Cancer
  • Montreal, Quebec, Canada
    Segal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial
May 3, 2022

Metastatic Pancreatic Adenocarcinoma Trial in France (Gemcitabine, Paclitaxel)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Bayeux, France
  • +25 more
May 17, 2022

Metastatic Pancreatic Cancer Trial in Scottsdale (diagnostic test, other, drug)

Completed
  • Metastatic Pancreatic Cancer
  • Safety Laboratories
  • +7 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Jul 14, 2021

Locally Advanced Pancreatic Adenocarcinoma Trial in France (Gabrinox, MRI-GUIDED STEREOTACTIC RADIOTHERAPY)

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • Gabrinox
  • MRI-GUIDED STEREOTACTIC RADIOTHERAPY
  • Dijon, Côte d'Or, France
  • +4 more
Jan 2, 2022

Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • (no location specified)
Feb 10, 2022

Pancreas Cancer Trial in Cincinnati (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • Folfirinox
  • +3 more
  • Tucson, Arizona
  • +1 more
Sep 13, 2022

Pancreatic Cancer Trial in New York (Biopsy, FOLFIRINOX, Ciprofloxacin)

Not yet recruiting
  • Pancreatic Cancer
  • Biopsy
  • +5 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 13, 2022

Pancreas Cancer Trial in Louisville (Irreversible Electroporation (IRE), Gemcitabine, FOLFIRINOX)

Recruiting
  • Pancreas Cancer
  • Irreversible Electroporation (IRE)
  • +2 more
  • Louisville, Kentucky
    University of Louisville
Oct 6, 2021

Pancreatic Cancer Trial in Worldwide (ABBV-927, Budiglimab, modified FOLFIRINOX)

Recruiting
  • Pancreatic Cancer
  • Springdale, Arkansas
  • +23 more
May 23, 2022